Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Genes, Chromosomes & Cancer|April 9, 2022
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective studyWenxian Wang, Xiaodong Gu, Jinfei Si, et al.
Cancer Investigation|April 14, 2024
A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal AdenocarcinomaXiaofeng Sun, Hao Song, Xiaoran Sun, et al.
Ebiomedicine|May 26, 2018
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic MelanomaWenjing Xiao, Nan Du, Taoyuan Huang, et al.
Aging|April 26, 2023
Senescence-related genes define prognosis, immune contexture, and pharmacological response in gastric cancerXiaogang Shen, Meng Wang, Wenxi Chen, et al.
International Journal of Clinical and Experimental Pathology|January 23, 2020
Genetic mutations in lung enteric adenocarcinoma identified using next-generation sequencingLi Lin, Wu Zhuang, Wenxian Wang, et al.
Journal of Clinical Laboratory Analysis|November 3, 2025
Epithelial-Mesenchymal Transition States and Metabolic Reprogramming Related Signatures Predict Prognosis and Therapeutic Responses in HER2-Positive Breast CancerYuhui Zheng, Yinduo Zeng, Mengping Xi, et al.
Aging|February 1, 2024
MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysisJin Tao, Jinshan Cui, Yu Xu, et al.
Aging|September 25, 2023
Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancerZheng Gong, Yuming He, Xiao Mi, et al.
Translational Oncology|January 13, 2017
Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK InhibitorXinru Chen, Yu Zhang, Jiabin Lu, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2022
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective studyWenxian Wang, Gen Lin, Yue Hao, et al.
Pageof 15